• Home
  •  / SentreHEART
ProfileJobs

SentreHEART

Suggest Edit
Healthcarehealthtechmedical devicessurgical solutions
SentreHEART is a medical device company that manufacturers the LARIAT Suture Delivery Device for remote delivery of a pre-tied suture loop. Innovation in catheter and suture delivery technology enables physicians to remotely deliver a 40mm pre-tied suture loop for immediate and complete soft tissue closure through access as small as 4.3mm and with no metal, clips or fabrics left behind.
TypeSubsidiary
Parent CompanyAtriCure
HQRedwood City, CA, US
Founded2005
Websitesentreheart.com
Cybersecurity ratingAMore
SentreHEART was founded in 2005 and is headquartered in Redwood City, CA, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at SentreHEART

Russell Seiber

Russell Seiber

President & CEO, Founder, Director
Chris Lowe

Chris Lowe

Chief Financial Officer
Robert Strasser

Robert Strasser

Vice President of Operations
Pam Simons

Pam Simons

Vice President of Clinical Affairs
Greg Fung

Greg Fung

Vice President of Research & Development
Richard M. Ferrari

Richard M. Ferrari

Executive Chairman
Show more

SentreHEART Office Locations

SentreHEART has an office in Redwood City
Redwood City, CA, US (HQ)
300 Saginaw Dr
Show all (1)

SentreHEART Financials and Metrics

Summary Metrics

Founding Date

2005

Total Funding

$69 m

Investors

U.S. Venture Partners (USVP), Prospect Venture Partners, Vivo Ventures, Decheng Capital, Vivo Capital, Deerfield
In total, SentreHEART had raised $69 m. SentreHEART is a subsidiary of AtriCure

SentreHEART Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

Learn more about our premium products
SecurityScorecard logo

SentreHEART Online and Social Media Presence

SentreHEART's Trends

Embed Graph

SentreHEART Company Culture

  • Overall Culture

    A+

    91/100

  • CEO Rating

    A+

    100/100

  • Compensation

    A+

    100/100

Learn more on Comparably

SentreHEART News and Updates

May 14, 2018

Impact of Existing and Emerging Atrial Appendage Occluder Market Trends 2017-2027

Future Market Insights has announced the addition of the “Atrial Appendage Occluder Market: Global Industry Analysis and Opportunity Assessment, 2017-2027"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
January 12, 2018

Left Atrial Appendage (LAA) Closure Devices Market Size will Escalate Rapidly in the Near Future

The global left atrial appendage (LAA) closure devices market is expected to register a significant CAGR over a forecast period. Posted via Industry Today. Follow us on Twitter @IndustryToday

 SentreHEART Frequently Asked Questions

  • When was SentreHEART founded?

    SentreHEART was founded in 2005.

  • Who are SentreHEART key executives?

    SentreHEART's key executives are Russell Seiber, Chris Lowe and Robert Strasser.

  • How many employees does SentreHEART have?

    SentreHEART has 29 employees.

  • Who are SentreHEART competitors?

    Competitors of SentreHEART include Fortimedix, Keranova and Procardia Medical.

  • Where is SentreHEART headquarters?

    SentreHEART headquarters is located at 300 Saginaw Dr, Redwood City.

  • Where are SentreHEART offices?

    SentreHEART has an office in Redwood City.

  • How many offices does SentreHEART have?

    SentreHEART has 1 office.